Researcher Profile

Researcher Profile

Cheng Dong, PhD

Cheng Dong, PhD

Department Head and Distinguished Professor, Biomedical Engineering
Scientific Program:Next-Generation Therapies
cxd23@psu.edu

Research Interests

  • Neoplasms
  • Melanoma
  • Neutrophils
  • Leukocytes
  • Cell Adhesion
  • Neoplasm Metastasis
  • Endothelial Cells
  • Intercellular Adhesion Molecule-1
  • Integrins
  • Endothelium
  • Pseudopodia
  • Interleukin-8

Recent Publications

2019

He, Y, Li, Q, Ma, C, Xie, D, Li, L, Zhao, Y, Shan, D, Chomos, SK, Dong, C, Tierney, JW, Sun, L, Lu, D, Gui, L & Yang, J 2019, 'Development of osteopromotive poly (octamethylene citrate glycerophosphate) for enhanced bone regeneration', Acta Biomaterialia, vol. 93, pp. 180-191. https://doi.org/10.1016/j.actbio.2019.03.050

2018

Ye, K, Kaplan, DL, Bao, G, Bettinger, C, Forgacs, G, Dong, C, Khademhosseini, A, Ke, Y, Leong, K, Sambanis, A, Sun, W & Yin, P 2018, 'Advanced Cell and Tissue Biomanufacturing', ACS Biomaterials Science and Engineering, vol. 4, no. 7, pp. 2292-2307. https://doi.org/10.1021/acsbiomaterials.8b00650
Aragon-Sanabria, V, Kim, GB & Dong, C 2018, From cancer immunoediting to new strategies in cancer immunotherapy: The roles of immune cells and mechanics in oncology. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1092, Springer New York LLC, pp. 113-138. https://doi.org/10.1007/978-3-319-95294-9_7
Sanabria, VA & Dong, C 2018, 'Integration of biochemical and biomechanical signals regulating endothelial barrier function', MCB Molecular and Cellular Biomechanics, vol. 15, no. 1, pp. 1-19. https://doi.org/10.3970/mcb.2018.015.001
Dong, C, Zahir, N & Konstantopoulos, K 2018, 'Preface', Advances in experimental medicine and biology, vol. 1092, pp. v-vi.
Kim, GB, Chen, Y, Kang, W, Guo, J, Payne, R, Li, H, Wei, Q, Baker, J, Dong, C, Zhang, S, Wong, PK, Rizk, EB, Yan, J & Yang, J 2018, 'The critical chemical and mechanical regulation of folic acid on neural engineering', Biomaterials, vol. 178, pp. 504-516. https://doi.org/10.1016/j.biomaterials.2018.03.059

2017

Tang, X, Loc, WS, Dong, C, Matters, GL, Butler, PJ, Kester, M, Meyers, C, Jiang, Y & Adair, JH 2017, 'The use of nanoparticulates to treat breast cancer', Nanomedicine, vol. 12, no. 19, pp. 2367-2388. https://doi.org/10.2217/nnm-2017-0202
Aragon-Sanabria, V, Pohler, SE, Eswar, VJ, Bierowski, M, Gomez, EW & Dong, C 2017, 'VE-Cadherin Disassembly and Cell Contractility in the Endothelium are Necessary for Barrier Disruption Induced by Tumor Cells', Scientific reports, vol. 7, 45835. https://doi.org/10.1038/srep45835

2016

Zhang, P, Feng, S, Liu, G, Wang, H, Fu, A, Zhu, H, Ren, Q, Wang, B, Xu, X, Bai, H & Dong, C 2016, 'CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation', Oncogene, vol. 35, no. 38, pp. 5056-5069. https://doi.org/10.1038/onc.2016.67
Xie, Z, Su, Y, Kim, GB, Selvi, E, Ma, C, Aragon-Sanabria, V, Hsieh, JT, Dong, C & Yang, J 2017, 'Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery', Small, vol. 13, no. 10, 1603121. https://doi.org/10.1002/smll.201603121
Zhang, P, Feng, S, Liu, G, Wang, H, Zhu, H, Ren, Q, Bai, H, Fu, C & Dong, C 2016, 'Mutant B-Raf(V600E) promotes melanoma paracellular transmigration by inducing thrombin-mediated endothelial junction breakdown', Journal of Biological Chemistry, vol. 291, no. 5, pp. 2087-2106. https://doi.org/10.1074/jbc.M115.696419

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)